In Vivo Evaluation of Melasma Pathologic Features and Treatment Response by 2-Photon Microscopy

Area of Science:

• Dermatology
• Medical Imaging
• Pathology

Background:

• Melasma is a challenging facial pigmentary disorder.
• Current diagnostic and efficacy assessment tools lack in vivo capabilities.

Purpose of the Study:

• To utilize two-photon microscopy (TPM) for noninvasive in vivo pathologic detection of melasma.
• To monitor therapeutic response to 2% hydroquinone cream using TPM.

Main Methods:

• An observational study involving 60 patients with melasma.
• Phase 1: Noninvasive TPM imaging of lesional and perilesional areas.
• Phase 2: Treatment with 2% hydroquinone cream for 12 weeks, with follow-up TPM and clinical assessments.

Main Results:

• TPM revealed increased melanin, reduced epidermal thickness, flattened rete ridges, and altered melanocytes in melasma lesions compared to perilesions.
• After 12 weeks of hydroquinone treatment, significant reductions in melasma area and severity index (mMASI) scores and dermoscopic scores were observed.
• TPM demonstrated significant decreases in epidermal melanin content and activated melanocytes at the dermal-epidermal junction post-treatment.

Conclusions:

• Two-photon microscopy (TPM) enables noninvasive in vivo detection of melasma's pathologic features.
• TPM can effectively assess cellular-level treatment responses to therapies like hydroquinone.
• TPM represents a novel paradigm for pigmentary disorder management, diagnosis, and treatment monitoring.